在体部计算机断层扫描基础上加做全身磁共振成像会改变转移性乳腺癌患者的治疗决策
本研究纳入101例转移性乳腺癌患者的210对全身磁共振成像(WB-MRI)与胸部、腹部和盆腔计算机断层扫描(CT-CAP)检查,比较两者对疾病分布和全身抗肿瘤治疗(SACT)疗效评估的差异。结果显示53.3%的检查中WB-MRI报告了CT-CAP未报告的额外病灶,28.0%的检查SACT评估存在差异,其中18.9%为WB-MRI报告进展而CT-CAP报告稳定。在34.7%的治疗改变检查中,仅WB-MRI报告了进展。作者认为WB-MRI改变了常规实践中的SACT决策,需进一步研究早期发现进展是否改善患者结局。
要点
- 53.3%的检查中WB-MRI报告了CT-CAP未报告的额外病灶。
- 28.0%的检查SACT评估存在差异,18.9%为WB-MRI报告进展而CT-CAP报告稳定。
- 34.7%的治疗改变检查中仅WB-MRI报告了进展。
核心结论
- 常规实践中WB-MRI的使用改变了SACT决策,需进一步研究WB-MRI早期发现进展是否改善患者结局。
研究设计与样本
- 研究纳入在CT-CAP后14天内接受WB-MRI的转移性乳腺癌患者,比较原始WB-MRI与CT-CAP报告中的疾病分布、范围及SACT疗效评估数据,并结合同期病历记录每个时间点的治疗决策;分析基于101例患者的210对WB-MRI与CT-CAP检查。
主要发现
- 53.3%的检查中WB-MRI报告了CT-CAP未报告的额外病灶。
- 28.0%的检查SACT评估存在差异,最常见为WB-MRI报告进展而CT-CAP报告稳定(18.9%)。
- 一线SACT中SACT评估不一致的发生率低于后续线SACT(15.0% vs 41.6%;p=0.0102)。
- 在34.7%的治疗改变检查中,仅WB-MRI报告了进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Accurate evaluation of distribution of disease and response to systemic anti-cancer therapy (SACT) is important in the optimal management of metastatic breast cancer. Whole-body magnetic resonance imaging (WB-MRI) has increased accuracy over computerised tomography of the chest, abdomen and pelvis (CT-CAP) for detecting liver and bone disease, but its effect on patient management is largely unexplored. This study investigates the effects of using WB-MRI alongside CT-CAP on SACT decisions in standard clinical practice for patients with metastatic breast cancer. METHODS: Metastatic breast cancer patients who had undergone WB-MRI within 14 d of CT-CAP were studied. Data on distribution and extent of disease and SACT response assessment from original WB-MRI and CT-CAP reports were compared. Contemporaneous medical records provided data on therapy decisions at each time point. RESULTS: Analyses were performed on 210 pairs of WB-MRI and CT-CAP in 101 patients. In 53.3% of episodes, WB-MRI reported additional sites of disease not reported on CT-CAP. Differences in SACT assessment were found in 28.0% of episodes, most commonly due to progressive disease (PD) on WB-MRI being reported as stable disease on CT-CAP (18.9%). Discordant SACT assessments were less common in first-line SACT than in subsequent lines of SACT (15.0% versus 41.6%; p = 0.0102). In 34.7% of episodes when SACT was changed, PD had been reported on WB-MRI only. CONCLUSIONS: SACT decisions in routine practice were altered by the use of WB-MRI. Further research is required to investigate whether earlier identification of PD by WB-MRI leads to improved patient outcomes.
引用
- Kosmin M, Makris A, Joshi PV, et al. The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer. Eur J Cancer. 2017. PMID: 28390297. doi:10.1016/j.ejca.2017.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。